Search Results - "Aboubacar, Soumah"
-
1
Application of the electrical resistivity method and the estimation of limestone volume: a case study
Published in Frontiers in earth science (Lausanne) (20-12-2023)“…The present work used the electrical resistivity approach to conduct a three-dimensional modeling and initial volume estimation of the limestone layer in the…”
Get full text
Journal Article -
2
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo
Published in Vaccines (Basel) (23-07-2024)“…During the 2018-2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine…”
Get full text
Journal Article -
3
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo
Published in Vaccines (Basel) (23-07-2024)“…During the 2018-2020 Ebola virus disease outbreak in Democratic Republic of the Congo, a phase 3 trial of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine…”
Get full text
Journal Article -
4
Les archives judiciaires, un outil de travail incontournable pour le tribunal de première instance de Kankan
Published in Akofena (01-09-2024)“…Résumé : Le tribunal de première instance, étant la structure de recours des citoyens et autres dans la préfecture de Kankan, ses archives sont d’un apport…”
Get full text
Journal Article -
5
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Published in The Lancet (British edition) (04-02-2017)“…Summary Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of…”
Get full text
Journal Article -
6
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Published in The Lancet (British edition) (29-08-2015)“…Summary Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus…”
Get full text
Journal Article -
7
Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea
Published in Vaccine (15-11-2019)“…As part of the ring vaccination trial in Guinea, Front Line Workers were invited to participate in a sub-study to provide additional information on the…”
Get full text
Journal Article -
8
Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea
Published in Vaccine (15-11-2019)“…Alongside the clinical aspects of the immunogenicity and safety trial of an Ebola vaccine deployed among front-line workers, a qualitative study was conducted…”
Get full text
Journal Article -
9
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea
Published in Vaccine (26-06-2020)“…•We found rVSVΔG-ZEBOV-GP to be immunogenic at 28- and 180-days post vaccination.•At 28 days post-vaccination, seroresponse rate was higher in the high-risk…”
Get full text
Journal Article -
10
Field investigation with real-time virus genetic characterisation support of a cluster of Ebola virus disease cases in Dubréka, Guinea, April to June 2015
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (22-03-2018)“…On 11 May 2015, the Dubréka prefecture, Guinea, reported nine laboratory-confirmed cases of Ebola virus disease (EVD). None could be epidemiologically linked…”
Get full text
Journal Article